BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 29846604)

  • 1. Long-Term Testosterone Supplementation in Older Men Attenuates Age-Related Decline in Aerobic Capacity.
    Traustadóttir T; Harman SM; Tsitouras P; Pencina KM; Li Z; Travison TG; Eder R; Miciek R; McKinnon J; Woodbury E; Basaria S; Bhasin S; Storer TW
    J Clin Endocrinol Metab; 2018 Aug; 103(8):2861-2869. PubMed ID: 29846604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testosterone Attenuates Age-Related Fall in Aerobic Function in Mobility Limited Older Men With Low Testosterone.
    Storer TW; Bhasin S; Travison TG; Pencina K; Miciek R; McKinnon J; Basaria S
    J Clin Endocrinol Metab; 2016 Jun; 101(6):2562-9. PubMed ID: 27050869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Testosterone Supplementation for 3 Years on Muscle Performance and Physical Function in Older Men.
    Storer TW; Basaria S; Traustadottir T; Harman SM; Pencina K; Li Z; Travison TG; Miciek R; Tsitouras P; Hally K; Huang G; Bhasin S
    J Clin Endocrinol Metab; 2017 Feb; 102(2):583-593. PubMed ID: 27754805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Testosterone Administration for 3 Years on Subclinical Atherosclerosis Progression in Older Men With Low or Low-Normal Testosterone Levels: A Randomized Clinical Trial.
    Basaria S; Harman SM; Travison TG; Hodis H; Tsitouras P; Budoff M; Pencina KM; Vita J; Dzekov C; Mazer NA; Coviello AD; Knapp PE; Hally K; Pinjic E; Yan M; Storer TW; Bhasin S
    JAMA; 2015 Aug; 314(6):570-81. PubMed ID: 26262795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testosterone Replacement Therapy Added to Intensive Lifestyle Intervention in Older Men With Obesity and Hypogonadism.
    Barnouin Y; Armamento-Villareal R; Celli A; Jiang B; Paudyal A; Nambi V; Bryant MS; Marcelli M; Garcia JM; Qualls C; Villareal DT
    J Clin Endocrinol Metab; 2021 Mar; 106(3):e1096-e1110. PubMed ID: 33351921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone and sex steroid administration in healthy aged women and men: a randomized controlled trial.
    Blackman MR; Sorkin JD; Münzer T; Bellantoni MF; Busby-Whitehead J; Stevens TE; Jayme J; O'Connor KG; Christmas C; Tobin JD; Stewart KJ; Cottrell E; St Clair C; Pabst KM; Harman SM
    JAMA; 2002 Nov; 288(18):2282-92. PubMed ID: 12425705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial.
    Marks LS; Mazer NA; Mostaghel E; Hess DL; Dorey FJ; Epstein JI; Veltri RW; Makarov DV; Partin AW; Bostwick DG; Macairan ML; Nelson PS
    JAMA; 2006 Nov; 296(19):2351-61. PubMed ID: 17105798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testosterone replacement and resistance exercise in HIV-infected men with weight loss and low testosterone levels.
    Bhasin S; Storer TW; Javanbakht M; Berman N; Yarasheski KE; Phillips J; Dike M; Sinha-Hikim I; Shen R; Hays RD; Beall G
    JAMA; 2000 Feb; 283(6):763-70. PubMed ID: 10683055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of testosterone replacement with a nongenital, transdermal system, Androderm, in human immunodeficiency virus-infected men with low testosterone levels.
    Bhasin S; Storer TW; Asbel-Sethi N; Kilbourne A; Hays R; Sinha-Hikim I; Shen R; Arver S; Beall G
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3155-62. PubMed ID: 9745419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men.
    Wang C; Swerdloff RS; Iranmanesh A; Dobs A; Snyder PJ; Cunningham G; Matsumoto AM; Weber T; Berman N;
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2839-53. PubMed ID: 10946892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testosterone Treatment and Coronary Artery Plaque Volume in Older Men With Low Testosterone.
    Budoff MJ; Ellenberg SS; Lewis CE; Mohler ER; Wenger NK; Bhasin S; Barrett-Connor E; Swerdloff RS; Stephens-Shields A; Cauley JA; Crandall JP; Cunningham GR; Ensrud KE; Gill TM; Matsumoto AM; Molitch ME; Nakanishi R; Nezarat N; Matsumoto S; Hou X; Basaria S; Diem SJ; Wang C; Cifelli D; Snyder PJ
    JAMA; 2017 Feb; 317(7):708-716. PubMed ID: 28241355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testosterone supplementation therapy for older men: potential benefits and risks.
    Gruenewald DA; Matsumoto AM
    J Am Geriatr Soc; 2003 Jan; 51(1):101-15; discussion 115. PubMed ID: 12534854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testosterone vs. aromatase inhibitor in older men with low testosterone: effects on cardiometabolic parameters.
    Dias JP; Shardell MD; Carlson OD; Melvin D; Caturegli G; Ferrucci L; Chia CW; Egan JM; Basaria S
    Andrology; 2017 Jan; 5(1):31-40. PubMed ID: 27792869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors influencing prostate-specific antigen response among men treated with testosterone therapy for 6 months.
    Morgentaler A; Benesh JA; Denes BS; Kan-Dobrosky N; Harb D; Miller MG
    J Sex Med; 2014 Nov; 11(11):2818-25. PubMed ID: 25131184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men: a randomized controlled trial.
    Emmelot-Vonk MH; Verhaar HJ; Nakhai Pour HR; Aleman A; Lock TM; Bosch JL; Grobbee DE; van der Schouw YT
    JAMA; 2008 Jan; 299(1):39-52. PubMed ID: 18167405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of aromatase inhibition in elderly men with low or borderline-low serum testosterone levels.
    Leder BZ; Rohrer JL; Rubin SD; Gallo J; Longcope C
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1174-80. PubMed ID: 15001605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of testosterone supplementation on whole body and regional fat mass and distribution in human immunodeficiency virus-infected men with abdominal obesity.
    Bhasin S; Parker RA; Sattler F; Haubrich R; Alston B; Umbleja T; Shikuma CM;
    J Clin Endocrinol Metab; 2007 Mar; 92(3):1049-57. PubMed ID: 17164307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptomatic response to testosterone treatment in dieting obese men with low testosterone levels in a randomized, placebo-controlled clinical trial.
    Ng Tang Fui M; Hoermann R; Prendergast LA; Zajac JD; Grossmann M
    Int J Obes (Lond); 2017 Mar; 41(3):420-426. PubMed ID: 28028318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effect of Testosterone on Cardiovascular Biomarkers in the Testosterone Trials.
    Mohler ER; Ellenberg SS; Lewis CE; Wenger NK; Budoff MJ; Lewis MR; Barrett-Connor E; Swerdloff RS; Stephens-Shields A; Bhasin S; Cauley JA; Crandall JP; Cunningham GR; Ensrud KE; Gill TM; Matsumoto AM; Molitch ME; Pahor M; Preston PE; Hou X; Cifelli D; Snyder PJ
    J Clin Endocrinol Metab; 2018 Feb; 103(2):681-688. PubMed ID: 29253154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of oral androstenedione on serum testosterone and adaptations to resistance training in young men: a randomized controlled trial.
    King DS; Sharp RL; Vukovich MD; Brown GA; Reifenrath TA; Uhl NL; Parsons KA
    JAMA; 1999 Jun; 281(21):2020-8. PubMed ID: 10359391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.